$HYFT News
Last published 1w ago
- 1w agoHYFTAMDNVDADHR+1Why the Next Edge in Antibody Discovery May Be What Labs RememberGlobeNewswireAUSTIN, Texas, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Wall Street Investor News Commentary - For most of the history of antibody discovery, the hard part was producing candidates. Generative models, high-throughput assays
- 2w agoHYFTMRNAMRKBNTXA Personalized Cancer Therapy Delivered Positive Phase 3 Results; The Next Race Is Picking Better TargetsGlobeNewswireAUSTIN, Texas, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Biotech Insider News Commentary - An mRNA-based cancer therapy designed around each patient’s own tumor has delivered positive Phase 3 results. On October 22, Merck and
- 2w agoHYFTMindWalk Holdings Corp. Announces Leadership UpdateBusiness WireCommercial Priorities Unchanged; LensAI™ Remains in Contracted, Recurring Deployments with Life Sciences Customers MindWalk Holdings Corp. ("MindWalk") (NASDAQ:HYFT), a Bio-Native AI company, today announced
- 3w agoHYFTAMDNVDAABSI+1AI Can Design Antibodies Faster Than Anyone Can Check Them for Immune Risk. That Gap Is Starting to Close.GlobeNewswireAUSTIN, Texas, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Wall Street Investor News Commentary - Antibodies have become one of medicine’s most valuable drug classes, with 144 FDA-approved antibody drugs on the market as of
- 3w agoHYFTMindWalk Screens 890,634 Antibody Sequences for Immune Risk in Under Five HoursBusiness WireNew white paper shows LensAI™ immunogenicity screening running at up to 43% lower cost per sequence on Amazon EC2 Hpc8a instances powered by AMD EPYC processors, making a critical drug-safety check practical at the
- 4w agoHYFTGENBMRNAABSI+1AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next TestGlobeNewswireNews Provided by Biotech Insider on behalf of MindWalk Holdings Corp. BOSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Biotech Insider News Commentary - For most of the past decade, the promise of AI in drug discovery was
- 4w agoHYFTMindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy StudiesBusiness WireSenior appointments from Pfizer, Novartis, Arbor Biotechnologies, and Orum Therapeutics bring preclinical development, structural biology, and portfolio strategy depth as MindWalk prepares its programs for preclinical
- 1mo agoHYFTPLTRSNOWMSFT+1Drug Discovery Informatics Market Projected to Reach $7.74 Billion by 2030 as AI Agents Need Biological ContextGlobeNewswireAUSTIN, Texas, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary - The global market for artificial intelligence in drug discovery is projected to grow from $5.09 billion in 2026 to $17.56 billion by
- 1mo agoHYFTMindWalk (NASDAQ: HYFT): Enterprise AI Has Found Its Ontology Layer. Biology Needs One Grounded in Biological FunctionBusiness WireAs data platforms and industry analysts converge on the "ontology layer" as the missing piece of agentic AI, MindWalk outlines why life sciences needs a biological context layer of its own, and why ReefIQ™,
- 1mo agoHYFTABCLLLYTWST+1AI Drug Discovery Forecasts Vary Widely as Sector Shifts to DeploymentPR NewswireTowards Healthcare projects that the global AI in drug discovery market will grow from $19.89 billion in 2025 to $160.49 billion by 2035, a compound...
- 1mo agoHYFTMindWalk Appoints Kim Remizowski to Board of Directors as Independent DirectorBusiness WireVeteran Banker and Licensed Fiduciary to Serve on the Audit Committee and the Compensation, Nomination and Governance Committee MindWalk Holdings Corp. ("MindWalk") (NASDAQ:HYFT), a Bio-Native AI company,
- 1mo agoHYFTMindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes EngineBusiness WireAntibody-antigen inference ran approximately 5x faster than in MindWalk's prior environment. The deployment, run with engineering partners AMD and Vultr on AMD Instinct™ MI325X GPUs, demonstrates the model-agnostic
- 1mo agoHYFTMindWalk Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 - MINDWALK HOLDINGS CORPEarnings Call TranscriptsHello, everyone. Thank you for joining us and welcome to MindWalk Reports financial results and recent business highlights for first quarter fiscal year 2027. After today's prepared remarks, we will host a question and a
- 1mo agoHYFTMindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027Business WireReefIQ™ launched commercially, and a US$30 million unsecured credit facility commitment, drawn only as needed, adds balance-sheet flexibility with no dilution. MindWalk Holdings Corp. ("MindWalk")
- 1mo agoHYFTMindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial ExpansionBusiness WireFacility carries a fixed 7.00% interest rate with no financial maintenance covenants, no warrants or equity conversion features, and no dilution to existing shareholders MindWalk Holdings Corp. ("MindWalk")
- 2mo agoHYFTMindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment ConferenceBusiness WireMindWalk Holdings Corp. ("MindWalk") (NASDAQ:HYFT), a Bio-Native AI company, today announced that it is participating in the H.C. Wainwright 28th Annual Global Investment Conference, held September 14 - 16,
- 2mo agoHYFTMindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026Business WireMindWalk to host an earnings conference call and webcast MindWalk Holdings Corp. ("MindWalk" or the "Company") (NASDAQ:HYFT), a Bio-Native AI company, today announced that it will report financial
- 2mo agoHYFTVEEVILMNCERT+1The Market Just Told You Which Layer Of AI Biology It Is Paying ForGlobeNewswireAUSTIN, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Market Updates News Commentary - Earnings season in life sciences technology has just delivered an unusually clean verdict. The company that owns the industry’s data
- 2mo agoHYFTTEMSDGRTWST+1AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030PR NewswireEquity Insider News Commentary - Pharmaceutical research is being rebuilt around artificial intelligence faster than the industry can absorb it....
- 2mo agoHYFTABCLABSILLY+1Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.GlobeNewswireNEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- USA News Group News Commentary - Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it
- 3mo agoHYFTTEMSDGRABCL+1AI Found an Influenza Target That Survives Viral MutationGlobeNewswireAUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and
- 3mo agoHYFTAMDRXRXABSI+2A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is HeadedPR NewswireAmerican News Group News Commentary - The race to bring artificial intelligence into drug discovery has become one of the most closely watched...
- 3mo agoHYFTMindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AIBusiness WireAt Advancing AI 2026, MindWalk unveils the first public demonstration of ReefIQ, its biological context layer for AI drug discovery, running on AMD Instinct™. MindWalk Holdings Corp. ("MindWalk")
- 3mo agoHYFTSDGRABCLRLAY+1An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the NumbersPR NewswireFor years, the promise of artificial intelligence in drug discovery has been easy to describe and hard to monetize. Plenty of companies can talk...
- 3mo agoHYFTMindWalk Holdings Corp. Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI InfrastructureBusiness WireFull-year revenue rose 46% to $15.6 million with gross margin expanding to 59%; net loss narrowed by more than half as MindWalk sharpened its focus on the BioIntelligence infrastructure powering AI drug
- 3mo agoHYFTABSIABCLVKTX+1As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22PR NewswireEquity Insider News Commentary - Artificial intelligence has moved from the edges of drug discovery to its center. The biggest pharmaceutical...
- 4mo agoHYFTMindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2026 on July 22, 2026Business WireMindWalk to host an earnings conference call and webcast MindWalk Holdings Corp. ("MindWalk" or the "Company") (NASDAQ:HYFT), a Bio-Native AI company, today announced that it will report financial
- 4mo agoHYFTABSICERTAZN+1As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the ModelsPR NewswireUSA News Group News Commentary — A growing consensus in artificial intelligence holds that the models themselves are becoming interchangeable, and...
- 4mo agoHYFTMindWalk Holdings Corp. (NASDAQ: HYFT) Added to the Russell 3000E Index, Expanding Institutional Investment OpportunityBusiness WireInclusion in FTSE Russell's June 2026 semi-annual reconstitution expands visibility among institutional investors and broadens eligibility for index-tracking funds managing more than $12 trillion in benchmarked
- 4mo agoHYFTTEMABCLSDGR+1As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the DataPR NewswireUSA News Group, There is a growing consensus in artificial intelligence that the models themselves are becoming interchangeable, and that lasting...
- 4mo agoHYFTMindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug DiscoveryBusiness WireThe patent covers the multi-dimensional biological representation layer organized around MindWalk’s HYFT® pattern anchors — the model-agnostic context layer designed to support ReefIQ™, LensAI™, and customer-selected
- 4mo agoHYFTABSIRXRXSDGR+1The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath ItPR NewswireEquity Insider News Commentary — The story the market has been telling itself about artificial intelligence and drug discovery is, at its core, a...
- 5mo agoABSIHYFTMindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug DiscoveryBusiness WireMindWalk Holdings Corp. ("MindWalk") (NASDAQ:HYFT), a bio-native AI company, today announced that President and Chief Executive Officer Dr. Jennifer Bath will join a virtual panel hosted by Jones, alongside Absci
- 5mo agoHYFTMindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug DiscoveryBusiness WireReefIQ turns fragmented biological data into governed, queryable context for AI-enabled drug discovery and biologics development. MindWalk Holdings Corp. ("MindWalk") (NASDAQ:HYFT), a bio-native AI company, today
- 5mo agoHYFTMindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent CampaignsBusiness WireHYFT® technology computationally identified and prioritized a pan-serotype dengue target before immunization. Preclinical data support the prediction at the binding level: immunization with immunogens designed on
- 5mo agoHYFTMindWalk Holdings Deploys Pandemic Response Platform via HYFT® Technology as Ebola and Hantavirus Outbreaks Expose the Limits of Strain-Specific CoverageBusiness WireMindWalk Holdings Corp. (NASDAQ:HYFT), a bio-native AI therapeutic research and technology company, today announced the launch of its Pandemic Response Platform, a deployment configuration of the Company's
- 5mo agoARGXCGEMHYFTIDXX+2The Biology Came First.Business WireOver 20 partner-owned drug programs have reached clinical trials as a result of antibody discovery work performed by MindWalk scientists — ten currently in active Phase 1–3. The same scientific depth and biological
- 8mo agoHYFTThird Quarter Fiscal Year 2026 Earnings CallMINDWALK HOLDINGS CORPEarnings Call TranscriptsPlease be advised that today's conference is being recorded. Good morning, ladies and gentlemen. Thank you for joining us today for MindWalk Holdings Corp's third quarter fiscal year 2026 earnings call. MindWALK trades o
- 8mo agoHYFTMindWalk Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2026 - MINDWALK HOLDINGS CORPEarnings Call TranscriptsPlease be advised that today's conference is being recorded. Good morning, ladies and gentlemen. Thank you for joining us today for MindWalk Holdings Corp's third quarter fiscal year 2026 earnings call. MindWALK trades o
- 8mo agoHYFTMindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial ResultsBusiness WireThird Consecutive Quarter of Year-Over-Year Revenue Growth | First Annual Enterprise LensAI™ Platform Contract | Launch of B cell Llama™ Nanobody Discovery Platform MindWalk Holdings Corp.
- 8mo agoHYFTMindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy EraBusiness WirePeer-reviewed study in ACS Biomacromolecules demonstrates modular VHH potency, cross-variant therapeutic activity, and a newly described immune-priming mechanism; MindWalk holds first right to commercialize jointly
- 8mo agoHYFTMindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026Business WireThe Company to host an earnings conference call via webcast MindWalk Holdings Corp. (NASDAQ:HYFT) ("MindWalk" or the "Company"), a Bio-Native AI therapeutic research and technology company, today announced that it
- 9mo agoHYFTMindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed TherapeuticsBusiness WireMindWalk Holdings Corp. (NASDAQ:HYFT) ("MindWalk" or the "Company"), a Bio-Native AI therapeutic research and technology company, today announced an application of its proprietary HYFT® technology designed to
- 11mo agoHYFTMindWalk Reports Record Growth and Announces Strategic Progress on Its AI Asset PipelineBusiness WireMindWalk (NASDAQ:HYFT), a BioNative AI biotherapeutic research and technology company combining in silico and wet lab operations for biologics discovery and development, today announced financial results for the second
- 11mo agoHYFTMindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2026 on December 15, 2025Business WireThe Company to host an earnings conference call via webcast MindWalk Holdings Corp. (NASDAQ:HYFT) ("MindWalk" or the "Company"), a Bio-Native AI therapeutic research and technology company, today announced that it will
- 1y agoBWAYHYFTICADAMCSMindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth StrategyBusiness WireMindWalk Holdings Corp.™ ("MindWalk," "Company," "we" or "us") (NASDAQ:HYFT), bio-native AI company today announces the appointment of industry veteran R. Scott Areglado as Chief Financial Officer (CFO),
- 1y agoHYFTMindWalk Appoints Dr. Thomas W. Lynch as Chief Business Officer to Accelerate Commercial ExpansionBusiness WireMindWalk Holdings Corp.™ ("MindWalk," "Company," "we" or "us") (NASDAQ:HYFT), a Bio-Native AI company today announced the appointment of industry veteran Thomas W. Lynch, Ph.D. as Chief Business Officer (CBO),
- 1y agoHYFTMindWalk Announces Share Repurchase ProgramBusiness WireMindWalk Holdings Corp. ("MindWalk" or the "Company") (NASDAQ: "HYFT"), a bio-native AI company, today announced that to underscore its confidence in MindWalk's future development and growth prospects, its Board of
- 1y agoHYFTMindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and LongevityBusiness WireCompany builds on earlier GLP-1 success with breakthrough AI-led insights into aging biology -- targeting the widely projected $60B longevity therapeutics market HYFT®-driven discovery supports co-administration
- 1y agoHYFTMindWalk Holdings Corp. (HYFT) Q1 2026 Earnings Call TranscriptEarnings Call Transcripts